Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Pharmacol.

Sec. Predictive Toxicology

Volume 16 - 2025 | doi: 10.3389/fphar.2025.1607919

This article is part of the Research TopicShaping the Future of Predictive Toxicology: Addressing Challenges and New Approach MethodologiesView all 3 articles

Integrated Neurobehavioral and Organ-Specific Safety Profiling of Baicalin: Acute/Subacute Toxicity Studies

Provisionally accepted
Jiali  YangJiali Yang1,2Mengyu  ChenMengyu Chen1,2Wan  ZhangWan Zhang3Jia  LiuJia Liu1,2Jing  ZhaoJing Zhao1,2Xin  PingXin Ping1,2Ye  LuYe Lu1,2Pei  HePei He1,2Lin  PeiLin Pei1,2*
  • 1Hebei University of Chinese Medicine, Shijiazhuang, China
  • 2Hebei Academy of Chinese Medicine Sciences, Shijiazhuang, Hebei Province, China
  • 3Hospital of Renmin University of China, Beijing, China

The final, formatted version of the article will be published soon.

Abstract Ethnopharmacological Relevance: Baicalin, an extract derived from the dried root of Scutellaria baicalensis Georgi (Huang Qin), has demonstrated neuroprotective properties. Nonetheless, the safety profile of baicalin has not yet been fully elucidated. Aim of the study: The objective was to characterize the acute and subacute toxicity profiles of baicalin across various organ systems, thereby establishing safe therapeutic windows for its clinical application in the treatment of chronic neurodegenerative disorders. Materials and Methods: Acute toxicity was assessed at 4000 mg/kg (OECD 423), while subacute toxicity evaluated escalating doses (1000–4000 mg/kg; OECD 407). Endpoints included survival, general behaviours, behavioral alterations, hematological/biochemical parameters, organ coefficients, and histopathology of brain, liver, and kidney. Results: Acute exposure showed no mortality (LD50 >4000 mg/kg) or lasting physiological effects, with only transient gastrointestinal symptoms in one subject. Subacute administration caused temporary gastrointestinal issues and occasional compulsive behaviors, all resolving within 24 hours. Behavioral assessments indicated intact neurocognitive function and emotional stability. Hematological profiles revealed sex-specific responses, with males showing higher lymphocyte percentages and females demonstrating renal changes. Biochemical analyses indicated liver metabolic changes, including alkaline phosphatase suppression and reduced triglycerides, along with mild nephrotoxic signs. Histopathological evaluations confirmed non-necrotic liver stress and unchanged hippocampal structure. Conclusions: Baicalin showed high acute safety with an LD50 over 4000 mg/kg in mice, and a subacute no-observed-adverse-effect level (NOAEL) of 2000 mg/kg, indicating its potential as a neuroprotective agent. However, 4000 mg/kg doses led to reversible hepatorenal toxicity and biochemical alterations, highlighting the need to monitor organ function during extended high-dose use.

Keywords: Baicalin1, Acute toxicity2, Subacute toxicity3, Behavioral tests4, Histopathology5, HematologyAbstract6

Received: 08 Apr 2025; Accepted: 14 Jul 2025.

Copyright: © 2025 Yang, Chen, Zhang, Liu, Zhao, Ping, Lu, He and Pei. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Lin Pei, Hebei University of Chinese Medicine, Shijiazhuang, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.